Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. [electronic resource]
Producer: 20030321Description: 626-30 p. digitalISSN:- 1590-8658
- Adolescent
- Adult
- Antibodies, Antineutrophil Cytoplasmic -- blood
- Antibodies, Monoclonal -- therapeutic use
- C-Reactive Protein -- analysis
- Child
- Colitis, Ulcerative -- blood
- Female
- Gastrointestinal Agents -- therapeutic use
- Humans
- Infliximab
- Male
- Methylprednisolone -- therapeutic use
- Middle Aged
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.